Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome

American Journal of Psychiatry

Volumn 161, Issue 9, 2004, Pages 1700-1702

  Bearden, Carrie E ^a   Jawad, Abbas F ^b   Lynch, David R ^b   Sokol, Set ^b   Kanes, Steven J ^b   McDonald McGinn, Donna M ^b   Saitta, Sulagna C ^b   Harris, Stacy E ^b   Moss, Edward ^b   Wang, Paul P ^b   Zackai, Elaine ^b   Emanuel, Beverly S ^b   Simon, Tony J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ARTICLE; ATTENTION; CHILD; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL ARTICLE; COGNITION; DIGEORGE SYNDROME; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMIZYGOTE; HUMAN; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; VELOCARDIOFACIAL SYNDROME; VERBAL MEMORY; WORKING MEMORY;

ALLELES; CATECHOL O-METHYLTRANSFERASE; CHILD; CHROMOSOMES, HUMAN, PAIR 22; COGNITION; DIGEORGE SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; VALINE;

EID: 4444362182     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.9.1700     Document Type: Article

References (14)

1. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250
2. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98:6917-6922
3. Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM, Dugaw KA, Paddock MN, Parson WW: Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 2001; 57:410-416
4. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D: A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159:652-654
5. Grossman MH, Emanuel BS, Budarf ML: Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 1992; 12:822-825
6. McDonald-McGinn DM, LaRossa D, Randall P, Emanuel BS, Zackai EH: The 22q11.2 deletion: screening, diagnostic workup, and outcome. Genet Test 1997; 1:99-108
7. Woodin M, Wang PP, Aleman D, McDonald-McGinn D, Zackai E, Moss E: Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 2001; 3:34-39
8. Bearden CE, Woodin M, Wang PP, Moss E, McDonald-McGinn D, Zackai E, Emanuel B, Cannon TD: Neuropsychological function in the 22q deletion syndrome. J Clin Exp Neuropsychol 2001; 23:447-464
9. Bassett AS, Chow EW: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999; 46:882-891
10. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56:940-945
11. Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996; 153:1541-1547
12. Lynch DR, Mozley D, Sokol S, Maas NMC, Balcer LJ, Siderowf AD: Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Movement Disord 2003; 18:804-812
13. Lezak M: Neuropsychological Assessment. New York, Oxford University Press, 1995
14. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE: Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psychiatry 1998; 43:425-431